From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
IBM and The Institute of Bioengineering and Nanotechnology Develop New Antimicrobial Hydrogel to Fight Superbugs and Drug-Resistant Biofilms
Applications range from protective coating to sterilize hospital surfaces and medical equipment or as an injection to more effectively treat patients
ASU partners with Life Technologies on U.S. DHHS funded project for commercial development of technologies to rapidly assess radiation dose
Beginning in fourth quarter of 2012, AZBio put out the call across Arizona’s bioscience community and asked….”What’ your viewpoint?” Members of Arizona’s bioscience community from across the state answered via a short survey focused on both policy and action priorities. Respondents ranked priorities on a scale from 5 to 1 with a 5 being “Most Important” […]
This morning PhRMA released a report, “Innovation in the Biopharmaceutical Pipeline: A Multi-Dimensional View”. The paper, by researchers at Analysis Group, examines the pipeline from several angles and helps to show the range of innovative research our companies are doing. The reports find: More than 5,000 medicines are in development globally 70% of medicines […]
- Open Door at ASU Biodesign Tempe
- AdvaMed Fly In 2020
- 02/25/2020 - 02/26/2020
- 2020 Health Policy Symposium - Improving Healthcare Through Transparency and Collaboration
- 2020 McKenna Lecture by Susan Dentzer
- BIO5 Inspiring Women in STEM